Storage characteristics of cord blood progenitor cells: Report of a multicenter study by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

Transfusion

Volumn 51, Issue 6, 2011, Pages 1284-1290

  Pamphilon, Derwood ^a,b,c,d,e,f   Curnow, Elinor ^a,b,c,d,e,f   Belfield, Helen ^a,b,c,d,e,f   Reems, Jo Anna ^a,b,c,d,e,f   McMannis, John ^a,b,c,d,e,f   Lecchi, Lucilla ^a,b,c,d,e,f   Szczepiorkowski, Zbigniew ^a,b,c,d,e,f   McKenna, David ^a,b,c,d,e,f  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b PUGET SOUND BLOOD CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL COUNT; CELL VIABILITY; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HUMAN; MONONUCLEAR CELL; ROOM TEMPERATURE; STORAGE TEMPERATURE; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD HEMATOPOIETIC PROGENITOR CELL TRANSPLANTATION;

ANTIGENS, CD34; BLOOD PRESERVATION; FETAL BLOOD; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; TEMPERATURE;

EID: 79958811092     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02967.x     Document Type: Article

References (16)

1. AABB Standards for Cellular Therapy Product Services. [cited 2010 July 17]. Available from: URL
2. International Standards for cord blood collection, processing and release for administration, 4th Edition. 2010 From the Foundation for the Accreditation of Cell Therapy (FACT). [cited 2010 July 17]. Available from: URL
3. Rowley SD,. Cryopreservation of hematopoietic cells. In:, Blume KG, Foreman SJ, Appelbaum FR, editors. Thomas' haematopoietic cell transplantation. 3rd ed. Oxford, UK: Blackwell Publishing; 2004. p. 599-61.
4. Solomon M, Wofford J, Johnson C, Regan D, Creer MH,. Factors influencing cord blood viability assessment before cryopreservation. Transfusion 2010; 59: 820-30.
5. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Arny M, Thomas L, Boyse EA,. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. PNAS 1989; 86: 3828-32. (Pubitemid 19141838)
6. Guttridge MG, Sidders C, Booth-Davey E, Pamphilon D, Watt SM,. Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 175-81. (Pubitemid 44102944)
7. Antonenas V, Garvin F, Webb M, Sartor M, Bradstock KF, Gottlieb D,. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport. Cytotherapy 2006; 8: 158-65. (Pubitemid 43675202)
8. Lazarus HM, Pecora AL, Sheat TC, Koç ON, White JM, Gabriel DA, Cooper BW, Gerson SL, Krieger M, Sing AP,. CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4oC dose not affect outcome. Bone Marrow Transplant 2000; 25: 559-66. (Pubitemid 30137874)
9. Rowley SD, Bensinger WI, Gooley TA,. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994; 83: 2731-6. (Pubitemid 24135868)
10. Directive 2004/23/EC of the European Parliament and Council on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Available from: URL
11. FDA Standards. July 17, 2010.
12. World Marrow Donor Association (WMDA) Standards. March 2005. [cited 2010 July 17]. Available from: URL
13. Standards for Haematopoietic Progenitor Cell Collection, Processing and Transplantation. 4th ed. 2008 From the Foundation for the Accreditation of Cell Therapy (FACT) and the Joint Accreditation Committee of ISCT-Europe and EBMT (JACIE). [cited 2010 July 17]. Available from: URL
14. Pamphilon DH, Selogie E, Szczepiorkowski ZM,. Transportation of cellular therapy products: report of a survey by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) collaborative. Vox Sang 2010; 99: 168-73. [Epub ahead of print].
15. Cleaver SA, Warren P, Kern M, Hurley CK, Raffoux C, Keller J, Kiesel U, Koza V, Marry E, Mitterschiffthaler A, Nakamura M, Okah CT, Persson U, Radde-Stepaniak T, Ranson L, Raymond J, do Rosario Sancho M, Varla-Leftherioti M, Wiegand T, Winterhager JM, Woodfield DG,. Donor work-up and transport of bone marrow-recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA). Bone Marrow Transplant 1997; 20: 621-9. (Pubitemid 27477574)
16. Lazarus HM, Fangyu K, Tarima S, Champlin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M,. Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. Biol Blood Marrow Transplant 2009; 15: 589-96.